- Revenues +11.6%, Adjusted EBITDA +13.1% - Organic development compared to pro forma figures Q1 2024: revenues -6.5%, adjusted EBITDA -9.3% - Q1 significantly influenced by revenue shift in syringe business - Guidance 2025 confirmed: organic revenue growth of 3-5% and adjusted EBITDA...
Hence then, the article about gerresheimer bormioli pharma boosts revenues and earnings was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Gerresheimer: Bormioli Pharma boosts revenues and earnings )
Also on site :
- Vue Cinema Chain Halts Liquidation Threat From Coca-Cola Bottling Giant After Settling Unpaid Bill
- Belgium corrects US on ‘peace board’ claim
- Numbrix 9 - January 23